IL45344A - Antiallergic compositions containing 21-acyloxy-16 -methyl-pregna-1,4,9(11)-triene-3,20-dione - Google Patents

Antiallergic compositions containing 21-acyloxy-16 -methyl-pregna-1,4,9(11)-triene-3,20-dione

Info

Publication number
IL45344A
IL45344A IL45344A IL4534474A IL45344A IL 45344 A IL45344 A IL 45344A IL 45344 A IL45344 A IL 45344A IL 4534474 A IL4534474 A IL 4534474A IL 45344 A IL45344 A IL 45344A
Authority
IL
Israel
Prior art keywords
pregna
triene
acyloxy
dione
methyl
Prior art date
Application number
IL45344A
Other languages
English (en)
Other versions
IL45344A0 (en
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of IL45344A0 publication Critical patent/IL45344A0/xx
Publication of IL45344A publication Critical patent/IL45344A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL45344A 1973-07-27 1974-07-25 Antiallergic compositions containing 21-acyloxy-16 -methyl-pregna-1,4,9(11)-triene-3,20-dione IL45344A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7327578A FR2244530B1 (xx) 1973-07-27 1973-07-27

Publications (2)

Publication Number Publication Date
IL45344A0 IL45344A0 (en) 1974-10-22
IL45344A true IL45344A (en) 1978-08-31

Family

ID=9123242

Family Applications (1)

Application Number Title Priority Date Filing Date
IL45344A IL45344A (en) 1973-07-27 1974-07-25 Antiallergic compositions containing 21-acyloxy-16 -methyl-pregna-1,4,9(11)-triene-3,20-dione

Country Status (14)

Country Link
US (1) US3923985A (xx)
JP (1) JPS5830319B2 (xx)
BE (1) BE818155A (xx)
CA (1) CA1029659A (xx)
CH (1) CH594698A5 (xx)
DE (1) DE2436234A1 (xx)
DK (1) DK401974A (xx)
FR (1) FR2244530B1 (xx)
GB (1) GB1480763A (xx)
IE (1) IE40163B1 (xx)
IL (1) IL45344A (xx)
NL (1) NL7410093A (xx)
SE (1) SE7409158L (xx)
ZA (1) ZA744750B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2383968A1 (fr) * 1977-03-18 1978-10-13 Roussel Uclaf Procede de preparation d'un steroide16a-methyle
PL2805720T3 (pl) 2008-05-28 2019-11-29 Reveragen Biopharma Inc Niehormonalne steroidowe modulatory nf-kb do leczenia choroby
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
CN102603842B (zh) * 2012-02-20 2013-10-23 湖南新合新生物医药有限公司 醋酸氢化可的松或其类似物的制备方法
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2944070A (en) * 1958-09-08 1960-07-05 Merck & Co Inc Preparation of 16alpha-lower alkyl steroids
GB935611A (en) * 1958-12-20 1963-08-28 Syntex Sa New cyclopentanophenanthrene derivatives and process for the production thereof
FR1461655A (fr) * 1965-10-28 1966-02-25 Roussel Uclaf Nouveau procédé de préparation d'un dérivé corticostéroïde et produits obtenus dans ce procédé

Also Published As

Publication number Publication date
IE40163B1 (en) 1979-03-28
GB1480763A (en) 1977-07-27
JPS5041847A (xx) 1975-04-16
BE818155A (fr) 1975-01-27
SE7409158L (sv) 1975-01-28
NL7410093A (nl) 1975-01-29
AU7165974A (en) 1976-01-29
CA1029659A (en) 1978-04-18
ZA744750B (en) 1975-08-27
DK401974A (xx) 1975-04-01
FR2244530B1 (xx) 1977-07-01
FR2244530A1 (xx) 1975-04-18
CH594698A5 (xx) 1978-01-31
IE40163L (en) 1975-01-27
US3923985A (en) 1975-12-02
IL45344A0 (en) 1974-10-22
JPS5830319B2 (ja) 1983-06-28
DE2436234A1 (de) 1975-02-13

Similar Documents

Publication Publication Date Title
AU6401073A (en) Compositions
CA1030859A (en) Polyolefin-elastomer compositions
AU7261774A (en) Biologically active compositions
CA1000503A (en) Blending
IL51679A (en) Praseodymium-cerium oxide compositions
CA1033750A (en) 5-methyl-isoflavone-derivatives, process for the preparation thereof and compositions containing the same
PH11410A (en) Novel steroids
BG31642A3 (en) Catalyist composition
AU7362974A (en) Antichlorosis compositions
IE37464L (en) Steroid compositions
IL45260A (en) 1,3-dihydroxy-8alpha-oestra-1,3,5(10)-triene derivatives
CA1015742A (en) Steroids
NZ178886A (en) Estra-1,3,5(10)-triene-(3 ,7 , 17 or 3 , 7 , 17 )-triols
ZA743438B (en) Substituted flavones, processes for their preparation and compositions containinh them
IL45344A (en) Antiallergic compositions containing 21-acyloxy-16 -methyl-pregna-1,4,9(11)-triene-3,20-dione
ZA747675B (en) Hydrocurable compositions
AU6729174A (en) Plaster compositions
JPS57154117A (en) Fragrant composition
ZA746062B (en) Biologically active compositions for ruminats
ZA745002B (en) Biologically active compositions
ZA747402B (en) Photopolymerisable composition
AU7349374A (en) Medicinal composition
ZA746059B (en) Photopolymerisable compositions
AU6940074A (en) Defoamer composition
AU499890B2 (en) Oral compositions